Rituximab Improves the Efficacy of High-Dose Chemotherapy With Autograft for High-Risk Follicular and Diffuse Large B-Cell Lymphoma: A Multicenter Gruppo Italiano Terapie Innnovative nei Linfomi SurveyCorrado Tarella, Alessandro Rambaldi, Andrea Gallamini et al.|Journal of Clinical Oncology|2008Cited by 72
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Marco Ladetto, Angela Gueli et al.|Annals of Hematology|2013Cited by 20
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Marco Ladetto, Francesco Bertoni et al.|Haematologica|2011Cited by 16
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentChiara Lobetti‐Bodoni, Marco Ladetto, Elisa Bernocco et al.|Mechanisms of Ageing and Development|2012Cited by 9
Benefit of Rituximab Addition to High-Dose Programs with Autograft for B-Cell Lymphoma: A Multicenter GITIL Survey on 957 Patients.Corrado Tarella, Alessandro Rambaldi, Salvatore Mirto et al.|Blood|2006Cited by 4